Relx Plc (LON:REL – Get Free Report) insider June Felix acquired 1,400 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The shares were purchased at an average price of GBX 3,504 ($46.87) per share, with a total value of £49,056 ($65,617.98).
Relx Stock Performance
REL stock opened at GBX 3,546 ($47.43) on Wednesday. The firm has a 50 day moving average of GBX 3,558.82 and a two-hundred day moving average of GBX 3,487.42. Relx Plc has a 12 month low of GBX 2,731.80 ($36.54) and a 12 month high of GBX 3,694.34 ($49.42). The company has a market capitalization of £65.96 billion, a price-to-earnings ratio of 3,544.00, a P/E/G ratio of 2.63 and a beta of 0.48. The company has a quick ratio of 0.45, a current ratio of 0.48 and a debt-to-equity ratio of 218.66.
Relx Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Thursday, September 5th. Investors of record on Thursday, August 1st were issued a GBX 18.20 ($0.24) dividend. This represents a yield of 0.52%. The ex-dividend date of this dividend was Thursday, August 1st. Relx’s dividend payout ratio is presently 6,000.00%.
Wall Street Analyst Weigh In
Read Our Latest Analysis on Relx
About Relx
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
Read More
- Five stocks we like better than Relx
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Invest in Insurance Companies: A Guide
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Industrial Products Stocks Investing
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.